Drug Development Services Market Size, Share, Growth Report, Forecast 2030

According to the report published by Zion Market Research, the global Drug Development Services Market size was valued at USD 19.85 billion in 2022 and is predicted to reach USD 42.30 billion by the end of 2030. The market is expected to grow with a CAGR of 11.41% during the forecast period 2023 to 2030. The report analyzes the global Drug Development Services Market ’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Drug Development Services industry.

Request Free Sample

Global Drug Development Services Market: Overview

Drug development is the process of designing and innovating new drugs. Some of the ways of drug development are random screening, molecular manipulation, molecular designing, drug metabolites, and serendipity. Drug development services are designed particularly to reduce the timeline and costs of drug discovery and development. Several sectors like pharmacology, medicine, biotechnology, and many others use drug development methods to discover and design new medications.

The process consists of assays, selection, depiction, production, and identification of aspirants for therapeutic usefulness. After a compound has presented its assessment values, a course of drug development takes place to proceed to clinical trials. The lead optimization, lead compound recognition, fragments based on drug designs, drug discovery selection, and drug target recognition altogether build up the core of drug development services. Drug development services are commonly used in anthropology, disaster victim, paternity testing, and forensics with DNA analysis proves to be an extremely important tool.

Global Drug Development Services Market: Growth Factors

One of the foremost factors in the global drug development services market is the increased demand for medicines. Moreover, technological advancements coupled with the growing adoption of innovative technology for the development of drugs along with a spike in demand for generic drugs and a surge in the number of patients further propel the growth in the global drug development services market. The inclination of prominent pharmaceutical companies to outsource a few tasks to avoid hurdles boosts the market growth.

The increasing outsourcing of clinical trials and analytical testing further fuels the market growth. The increasing geriatric population and growing demand for generic drugs bolster the growth of the global drug development services market. The surging number of manufacturers, organizations, and contract development are fostering the proliferation of the pharmaceutical industry and boost market growth.

Various factors like awareness regarding treatments of chronic diseases, a spike in unmet medical requirements, increase in the number of patients, patent expiration of major drugs, and efficient regulatory guidelines for drug development also contribute significantly to the growth of the global drug development services market.

Request Free Sample

Global Drug Development Services Market: Segmentation

The global drug development services market can be segmented into the process, type, drug, therapeutic area, company, and region.

By process, the market can be segmented into candidate validation, lead optimization, hit-to-lead identification, target validation, and target selection.

By type, the market can be segmented into drug metabolism & pharmacokinetics, biological services, and medicinal chemistry. Among these, the medicinal segment dominates the market due to the broad spectrum utilization of medicinal chemistry in a different phase of preclinical trials. Moreover, the growing support from a biotechnology company, academics, and large pharmaceutical companies also boosts the growth of the segment.

Request Free Sample

By drug, the market can be segmented into biologics, infectious disease diagnostics, and small molecules. The small molecule segment holds the largest share in the global drug development services market as they are well-defined, simple, and easy to characterize. The growth can be attributed to the capability of entering the cell quickly and efficiently affects the molecules to cause the cancer cells to die.

By therapeutic area, the market can be segmented into cardiovascular disease, digestive system disease, immune system & infectious disease, neurology, oncology, and other therapeutic areas. The oncology segment holds the hegemony over others owing to the growing number of cancer patients which subsequently surged need for cancer therapies.

By company, the market can be segmented into tier 3, tier 2, and tier 1 pharmaceutical companies.

Drug Development Services Market : Report Scope

Global Drug Development Services Market: Regional analysis

North America holds the largest share in the global drug development services market due to the presence of prominent and well-established players in the region. Moreover, increasing expenditure on research and development activities by biopharmaceutical and pharmaceutical companies also fuels regional growth.

Europe is also a potential region for the growth of the global drug development services market due to the availability of the latest and innovative technology for drug development and research. Asia Pacific is also expected to witness huge growth with a high CAGR during the forecast period.

Global Drug Development Services Market: Competitive Players

Some of the significant players in the global drug development services market are:-

• BioDuro
• SRI International
• Selvita S.A.
• AstraZeneca PLC
• Dalton Pharma Services
• Advinus Therapeutics
• Viva Biotech
• Piramal Enterprises Ltd.
• Lonza Group AG
• Laboratory Corporation of America Holdings
• Jubilant Life Sciences
• Albany Molecular Research Inc.
• GVK Biosciences Private Limited
• Covance
• Agilent Technologies Ubiquigent
• GenScript Biotech Corporation
• WuXi AppTec
• Eurofins Scientific
• Evotec A.G.
• Charles River Laboratories International, Inc.
• Albany Molecular Research, Inc.
• Thermo Fisher Scientific, Inc.

Drug Development Services Market: Segmentation

By Process:

• Candidate validation
• Lead optimization
• Hit-to-lead identification
• Target validation
• Target selection

By Type:

• Drug metabolism & pharmacokinetics
• Biological services
• Medicinal chemistry

By Drug:

• Biologics,
• Infectious disease diagnostics
• Small molecules

By Therapeutic area:

• Cardiovascular disease
• Digestive system disease
• Immune system & infectious disease
• Neurology, oncology
• Other therapeutic areas

By Company:

• Tier 3
• Tier 2,
• Tier 1 Pharmaceutical Companies

By Region:

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.